Marathon Partners Equity Management’s Xometry XMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.6M Sell
112,500
-500
-0.4% -$46.2K 11.34% 5
2026
Q2
$10.9M Sell
113,000
-2,000
-2% -$143K 10.18% 4
2026
Q1
$4.7M Hold
115,000
– – 5.32% 6
2025
Q4
$6.84M Sell
115,000
-162,500
-59% -$9.16M 6.8% 5
2025
Q3
$15.1M Sell
277,500
-5,000
-2% -$217K 10.87% 5
2025
Q2
$9.5M Buy
282,500
+17,500
+7% +$513K 8.29% 5
2025
Q1
$6.6M Buy
265,000
+10,500
+4% +$330K 6.76% 6
2024
Q4
$10.9M Buy
+254,500
New +$7.2M 9.44% 4
2023
Q4
$7.38M Buy
205,500
+55,500
+37% +$1.19M 11.5% 3
2023
Q3
$2.55M Buy
150,000
+125,000
+500% +$2.37M 3.86% 9
2023
Q2
$530K Buy
25,000
+5,000
+25% +$87.4K 0.66% 25
2023
Q1
$299K Buy
+20,000
New +$526K 0.39% 28

Other funds holding XMTR

Marathon Partners Equity Management's XMTR Position: Q3 2026 in Review

Marathon Partners Equity Management reduced its Xometry (XMTR) stake by 0.44% in Q3 2026, selling an estimated $46.2K and leaving 112,500 shares worth $11.6M. The position accounts for 11.34% of the portfolio, ranked #5.

Marathon Partners Equity Management first reported a position in XMTR in Q1 2023 and has held it in 12 quarters since. The position peaked at $15.1M in Q3 2025. 312 funds tracked by Wall St. Rank hold XMTR as of Q3 2026.

  • Marathon Partners Equity Management held 112,500 shares of Xometry worth $11.6M as of Q3 2026.
  • Marathon Partners Equity Management sold 500 Xometry shares in Q3 2026, an estimated $46.2K.
  • Xometry made up 11.34% of Marathon Partners Equity Management's portfolio in Q3 2026, its #5 holding.
  • Marathon Partners Equity Management first reported a position in Xometry in Q1 2023 and has held it in 12 quarters since.
  • Marathon Partners Equity Management's Xometry position peaked at $15.1M in Q3 2025.
  • 312 funds tracked by Wall St. Rank held Xometry as of Q3 2026.

Based on Marathon Partners Equity Management's 13F filing for Q3 2026, filed 16 Nov 2026.